HuagongsheHuagongshe Chemistry Print Report · For research reference only
Farnesyl acetone → (6R,10R)-6,10,14-trimethylpentadecan-2-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Farnesyl acetone | HCID 1711945 | — |
| Reactant | (6S,10S)-6,10,14-trimethylpentadecan-2-one | HCID 1810797 | — |
| Product | (6R,10R)-6,10,14-trimethylpentadecan-2-one | HCID 1810793 | — |
| Product | (6R,10S)-6,10,14-trimethylpentadecan-2-one | HCID 1810794 | — |
| Product | (6S,10R)-6,10,14-trimethylpentadecan-2-one | HCID 1810796 | — |
| Product | (6S,10S)-6,10,14-trimethylpentadecan-2-one | HCID 1810797 | — |
Reaction Steps
Specifically, it has been found that using the R-isomer of catalyst of formula (I) in the hydrogenation of E,E-farnesylacetone (=(5E,9E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one) the hydrogenation product (6S,10S)-6,10,14-trimethylpentadecan-2-one is formed in more than 96% in respect to all of the possible stereoisomers (i.e. (6S,10S)-6,10,14-trimethylpentadecan-2-one, (6S,10R)-6,10,14-trimethylpentadecan-2-one, (6R,10S)-6,10,14-trimethylpentadecan-2-one and (6R,10R)-6,10,14-trimethylpentadecan-2-one). Hence, the corresponding (6S,10R)- and (6R,10S)- and (6R,10R)-isomers are only formed only in smaller amounts.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09181163B2 |
| Source dataset | uspto-grants-2015_11 |
| ORD ID | ord-484ef40a30bf43fcbcd378750d863e41 |
| Source note | uspto-grants-2015_11 |